Date published: 2025-12-22

00800 4573 8000

SCBT Portrait Logo
Seach Input

TAJ-β Inhibitoren

TAJ-β inhibitors represent a specialized class of chemical compounds designed to specifically inhibit the function of the TAJ-β protein, a molecule known to play a role in various cellular regulatory pathways. TAJ-β inhibitors operate by binding to the active sites or key functional domains of the TAJ-β protein, thus preventing its normal activity within the cell. These inhibitors are often developed to fit the precise structural features of the TAJ-β protein, ensuring that they can effectively block its interactions or catalytic actions. The inhibitors may target different regions of the protein, such as its binding pockets or allosteric sites, depending on their mode of action and the specific mechanism by which they interfere with the protein's function. The chemical design of TAJ-β inhibitors is crucial for achieving a high degree of specificity, ensuring they interact with TAJ-β while minimizing interaction with other proteins.

TAJ-β inhibitors are synthesized using advanced organic synthesis techniques that allow the precise assembly of molecules with defined structural features. These compounds often feature a combination of hydrophobic and hydrophilic regions that are designed to complement the three-dimensional shape of the TAJ-β protein. Some inhibitors may include functional groups capable of forming strong covalent or non-covalent bonds with the protein's active sites, thereby enhancing their inhibitory potency. The solubility, stability, and reactivity of these inhibitors are carefully considered during their design, as these properties influence how effectively the inhibitor can interact with TAJ-β under different conditions. The diversity in the structural composition of TAJ-β inhibitors allows for the fine-tuning of their binding affinities, making them a valuable class of compounds for studying the biochemical functions and regulatory mechanisms associated with the TAJ-β protein.

Artikel 1 von 10 von insgesamt 11

Anzeigen:

ProduktCAS #Katalog #MengePreisReferenzenBewertung

SB 202190

152121-30-7sc-202334
sc-202334A
sc-202334B
1 mg
5 mg
25 mg
$30.00
$125.00
$445.00
45
(1)

Hemmt p38 MAPK und beeinflusst damit möglicherweise die Entzündungsreaktionswege, an denen TAJ-β beteiligt sein könnte.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K-Inhibitor, könnte Signalwege unterbrechen, die für das Überleben und die Vermehrung von Zellen wichtig sind.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK-Inhibitor, könnte die mit der TAJ-β-Aktivität verbundenen Stressreaktionswege und die Apoptose beeinflussen.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

MEK-Inhibitor, der möglicherweise den MAPK/ERK-Signalweg beeinflusst, was für die Funktion von TAJ-β von Bedeutung sein könnte.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Ein weiterer PI3K-Inhibitor könnte weitere Auswirkungen auf die Signalwege haben, an denen TAJ-β vermutlich beteiligt ist.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTOR-Inhibitor, könnte das Zellwachstum und die mit TAJ-β verbundenen Autophagieprozesse modulieren.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

RAF-Kinase-Inhibitor, könnte die Zellwachstums- und Differenzierungswege beeinflussen, an denen TAJ-β beteiligt ist.

Z-VAD-FMK

187389-52-2sc-3067
500 µg
$74.00
256
(6)

Pan-Caspase-Inhibitor, der möglicherweise die Apoptosewege beeinflusst, die TAJ-β regulieren könnte.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Proteasom-Inhibitor, könnte die für die Funktion von TAJ-β relevanten Wege des Proteinabbaus beeinflussen.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

Moduliert NF-κB und andere Signalmoleküle, was sich auf Entzündungen und Zellwachstum auswirken kann.